Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Prucalopride succinate | 179474-85-2 | 99.9% | 100 MG
SDP

Catalog No. 5000340898
Encompass_Preferred

Prucalopride succinate is an orally active, selective, and specific 5-HT4 receptor agonist with high affinity for human 5-HT4a/4b receptors. It improves intestinal motility by promoting regeneration of the intestinal nervous system in rats and shows anticancer activity by blocking the PI3K/AKT/mTor signaling pathway. This compound is suitable for research on chronic constipation, pseudo-intestinal obstruction, and cancer.

  • Orally active, selective, and specific 5-HT4 receptor agonist.
  • High affinity for human 5-HT4a/4b receptors (pKi values of 8.6 and 8.1, respectively).
  • Improves intestinal motility by promoting regeneration of the intestinal nervous system in rats.
  • Shows anticancer activity by blocking the PI3K/AKT/mTor signaling pathway.
  • Can be used in studies of chronic constipation, pseudo-intestinal obstruction, and cancer.
  • Available in solid form, white to off-white in color.
  • Purity of 99.9%.

Catalog No. 50-003-40898 Supplier Medchemexpress LLC Supplier No. HY12694100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Prucalopride succinate is an orally active, selective, and specific 5-HT4 receptor agonist with high affinity for human 5-HT4a/4b receptors. It improves intestinal motility by promoting regeneration of the intestinal nervous system in rats and shows anticancer activity by blocking the PI3K/AKT/mTor signaling pathway. This compound is suitable for research on chronic constipation, pseudo-intestinal obstruction, and cancer.

  • Orally active, selective, and specific 5-HT4 receptor agonist.
  • High affinity for human 5-HT4a/4b receptors (pKi values of 8.6 and 8.1, respectively).
  • Improves intestinal motility by promoting regeneration of the intestinal nervous system in rats.
  • Shows anticancer activity by blocking the PI3K/AKT/mTor signaling pathway.
  • Can be used in studies of chronic constipation, pseudo-intestinal obstruction, and cancer.
  • Available in solid form, white to off-white in color.
  • Purity of 99.9%.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.